Back to Search
Start Over
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches
- Source :
- International Journal of Molecular Sciences. 23:5242
- Publication Year :
- 2022
- Publisher :
- MDPI AG, 2022.
-
Abstract
- Multiple Myeloma (MM) is a malignant growth of clonal plasma cells, typically arising from asymptomatic precursor conditions, namely monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM). Profound immunological dysfunctions and cytokine deregulation are known to characterize the evolution of the disease, allowing immune escape and proliferation of neoplastic plasma cells. In the past decades, several studies have shown that the immune system can recognize MGUS and MM clonal cells, suggesting that anti-myeloma T cell immunity could be harnessed for therapeutic purposes. In line with this notion, chimeric antigen receptor T cell (CAR-T) therapy is emerging as a novel treatment in MM, especially in the relapsed/refractory disease setting. In this review, we focus on the pivotal contribution of T cell impairment in the immunopathogenesis of plasma cell dyscrasias and, in particular, in the disease progression from MGUS to SMM and MM, highlighting the potentials of T cell-based immunotherapeutic approaches in these settings.
- Subjects :
- Smoldering Multiple Myeloma
T cell immunity
T-Lymphocytes
Organic Chemistry
Paraproteinemias
General Medicine
immunotherapy
MGUS
multiple myeloma
plasma cells
tumor microenvironment
Disease Progression
Humans
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Catalysis
Computer Science Applications
Inorganic Chemistry
Physical and Theoretical Chemistry
Molecular Biology
Spectroscopy
Subjects
Details
- ISSN :
- 14220067
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- International Journal of Molecular Sciences
- Accession number :
- edsair.doi.dedup.....8f262d44969628b8aeed74fed6562450
- Full Text :
- https://doi.org/10.3390/ijms23095242